BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 950,000 Value ($000) $1,066 Avg Close — Range —
Q3 2025
Shares 1,450,000 Value ($000) $1,428 Avg Close — Range —
Q2 2025
Shares 2,500,000 Value ($000) $2,328 Avg Close — Range —
Q1 2025
Shares 15,000,000 Value ($000) $13,448 Avg Close — Range —
Q4 2023
Shares 5,000,000 Value ($000) $4,235 Avg Close — Range —
Q3 2023
Shares 5,000,000 Value ($000) $3,725 Avg Close — Range —
Q2 2023
Shares 5,000,000 Value ($000) $3,069 Avg Close — Range —
Q1 2023
Shares 5,250,000 Value ($000) $3,346 Avg Close — Range —
Q4 2022
Shares 6,250,000 Value ($000) $2,324 Avg Close — Range —
Q3 2022
Shares 6,250,000 Value ($000) $3 Avg Close — Range —
Q2 2022
Shares 2,750,000 Value ($000) $1 Avg Close — Range —
Q1 2022
Shares 5,900,000 Value ($000) $2,732 Avg Close — Range —